Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Ovarian Cancer

News digest – Brexit, viral treatments, alcohol, and… prostate cancer screening?

In this week's cancer news there's Brexit plans, viruses being used as treatments, and disagreements over screening for prostate cancer.

Targeted drug helps keep some advanced ovarian cancers at bay

Unpublished trial results have found that a drug which targets genetic vulnerabilities in tumour cells can delay some advanced ovarian cancers from worsening.

Study estimates breast and ovarian cancer risk linked to faulty BRCA genes

A new study has estimated the ages at which women with faults in two particular genes are most at risk of developing breast and ovarian cancer.

New test could detect ovarian cancer patients who are strongly responding to treatment

Scientists might be able to quickly predict how ovarian cancer patients are likely to respond to chemotherapy treatment using a simple blood test.

Meet our new research fellows 2016

Find out how our new up and coming researchers plan to tackle some of the big scientific questions in cancer.

Professor Stan Kaye awarded lifetime achievement prize

Cancer clinician Professor Stan Kaye has been awarded the Lifetime Achievement in Cancer Research Prize by Cancer Research UK today.

All women with ovarian cancer should be offered genetic testing – so why aren’t they?

Recent research has reinforced the need for all women with ovarian cancer to receive genetic testing, but they aren't. We explore why.

Dundee research explains drug resistance in ovarian cancer

Scientists in Dundee have uncovered important information about how ovarian cancer becomes resistant to certain treatments.

Building tumours in the lab – a how to guide

Our scientists in London are taking apart tumours and rebuilding artificial versions in the lab to help test the latest treatments.

Leukaemia drug shows potential for rare type of ovarian cancer

A drug already approved for leukaemia patients could also be used to treat a specific type of ovarian cancer.

Pages